| Financial Year |
March 31 2023 |
| Monetary Funds |
1,236,723,684.94 |
| Held-for-trading Financial Assets |
81,701,100.80 |
| Notes Receivable |
5,575,703.79 |
| Accounts Receivable |
139,360,791.25 |
| Advances to Suppliers |
56,751,926.11 |
| Other Receivables |
2,345,914.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,381,836.80 |
| Inventories |
170,253,323.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,918,026.57 |
| Total Current Assets |
1,700,854,323.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
655,019,843.89 |
| Investment Properties |
-- |
| Fixed Assetes |
779,390,097.96 |
| Under-construction Projects |
79,028,551.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,061,664.21 |
| R&D expenses |
15,898,085.31 |
| Goodwill |
500,000.00 |
| Long-Term Deferred and Prepaid Expenses |
26,406,710.36 |
| Deferred Income Tax Assets |
23,767,306.97 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,685,269,322.90 |
| Total Assets |
3,386,123,646.22 |
| Short-Term Loans |
270,263,611.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,702,138.87 |
| Accounts Payable |
80,993,385.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,901,520.53 |
| Taxes Payable |
9,863,937.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
181,770,918.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,028,483.55 |
| Other Current Liabilities |
8,583,230.29 |
| Sub-Total of Current Liabilities |
662,554,723.70 |
| Long-term Loans |
421,100,648.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
124,039,472.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
633,288,460.17 |
| Total Liabilities |
1,295,843,183.87 |
| Paid-In Capital(Or Share Stock) |
316,600,050.00 |
| Capital Surplus |
1,042,846,015.70 |
| Surplus Reserve |
158,300,025.00 |
| LESS:Treasury Stock |
47,793,987.02 |
| Undistributed Profits |
609,882,508.76 |
| Minority Stockholder's Interest |
10,445,849.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,079,834,612.44 |
| Owner's Equity（Stockholder's Equity） |
2,090,280,462.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,386,123,646.22 |
